Project Grant R34DA063047
Award Date
6/15/25
Completion Date
5/31/28
Dollars Obligated
$677K
Federal Agency
National Institute on Drug Abuse
Federal Grant Program
93.279
Assistance Type
Project Grant
Place of Performance
Florida, USA
Similar Awards
This $672,206 Project Grant awarded by the National Institute on Drug Abuse (NIDA) under the Drug Use and Addiction Research Programs (CFDA 93.279) aims to increase HIV and substance use prevention and treatment for adolescent and young adult (AYA) sexual violence survivors. The key activities include: Tailoring existing Sexual Assault Nurse Examiner (SANE) services to incorporate same-day HIV prophylaxis and substance use prevention, informed by interviews with 20 AYA survivors and 20 key...
This Project Grant award from the National Institute on Drug Abuse (NIDA), under the Drug Use and Addiction Research Programs (CFDA 93.279), aims to transform systems of care in Washington state prisons to address HIV, HIV risk, and substance use disorders. The $2,332,500 award will be used to: 1) Build the foundation for a prison learning health system, including quality metrics and a patient advisory board; 2) Define gaps in care access for key conditions like HIV, hepatitis C, and...
This Project Grant award, valued at $1,192,612 and awarded by the National Institute on Drug Abuse (NIDA), supports a research initiative to integrate HIV prevention services into clinical care settings for people with opioid use disorder (OUD). The project aims to address the public health crisis of opioid use and the higher risk of HIV infection among those with OUD. Key elements of the study include: Analyzing healthcare utilization data to assess OUD patients' engagement with HIV...
The National Institute on Drug Abuse (NIDA) awarded a $375,000 Project Grant under the Drug Use and Addiction Research Programs (CFDA 93.279) to The Johns Hopkins University to evaluate the impact of a status-neutral, person-centric intervention in New Delhi, India on HIV incidence, viral suppression, and mortality among people who inject drugs (PWID). The project aims to 1) assess the direct impact of the intervention on PWID in New Delhi, 2) investigate the diffusion of the intervention over...
This Project Grant award of $157,684 from the National Institute on Drug Abuse (NIDA) under the Drug Use and Addiction Research Programs (CFDA 93.279) aims to understand inequities in harm reduction services provided to persons with opioid use disorder in hospital settings. The key products and services to be delivered under this award include: Developing and validating a natural language processing (NLP) system to identify patterns of harm reduction language and other relevant data in...
This federal Project Grant award from the National Institute on Drug Abuse (NIDA), under the Drug Use and Addiction Research Programs (CFDA 93.279), provides $1,607,146 to NDRI-USA Inc., a non-profit research organization, for the project "TOGETHER AGAINST OVERDOSE: COMMUNITY DEVELOPED TECHNOLOGY TO ENCOURAGE DRUG CHECKING, DISTRIBUTION OF HARM REDUCTION SUPPLIES, AND LINKAGE TO SERVICES." The project aims to develop technology-based interventions in English and Spanish to increase...
This Project Grant award, with a total funding amount of $2,707,828, was issued by the National Institute on Drug Abuse (NIDA), which administers the Drug Use and Addiction Research Programs (CFDA 93.279). The grant, titled "PROJECT ACCESS: ADVANCING EQUITABLE ACCESS TO HIV/HCV TESTING THROUGH STRUCTURAL TRANSFORMATION IN SYRINGE SERVICES PROGRAMS: A CLUSTER RANDOMIZED TRIAL", aims to evaluate the effectiveness of the ACCESS implementation strategy in improving the uptake of HIV/HCV...
This federal Project Grant award for $873,784 from the National Institute on Drug Abuse (NIDA) under the Drug Use and Addiction Research Programs (CFDA 93.279) will support the development and pilot testing of an intervention called Project Vuselela. The intervention integrates peer navigation and family engagement to improve antiretroviral therapy (ART) adherence and opioid substitution therapy (OST) continuation among people who inject drugs (PWID) in South Africa. The primary goals are to...
This federal Project Grant award, valued at $687,416, was issued by the National Institute on Drug Abuse (NIDA) under the Drug Use and Addiction Research Programs (CFDA 93.279). The award aims to develop latency-promoting agents (LPAs) that can "block" HIV reactivation and "lock" the virus in a silenced state, particularly in the context of substance use disorder (SUD). The key objectives are to: 1) Determine the mechanisms by which CDK9 inhibition and PP2A activation can...
This $2,316,128 Project Grant award from the National Institute on Drug Abuse (NIDA) under the Drug Use and Addiction Research Programs (CFDA 93.279) aims to design tailored harm reduction strategies to address the overdose crisis across six distinct jurisdictions. The project, titled "REVERSING OVERDOSE EPIDEMICS THROUGH SIMULATION, COLLABORATION, AND UNIFIED EFFORTS (RESCUE)", will collaborate with health departments and community partners to assess the effectiveness,...